MODIFIED siRNA AND PHARMACEUTICAL COMPOSITION

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20180214574A1
SERIAL NO

15749191

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Double-stranded modified siRNA targeting a RecQL1 helicase gene includes a sense strand including the nucleotide sequence shown in SEQ ID NO: 1, and an antisense strand including the nucleotide sequence shown in SEQ ID NO: 2, wherein the sense strand includes 2′-substituted nucleotides at positions 2, 3, 4 and 13 in the nucleotide sequence shown in SEQ ID NO: 1, the sense strand further includes a 2′-substituted nucleotide(s) at one or more positions selected from the group consisting of positions 12, 14, 17, 18 and 19 in the nucleotide sequence shown in SEQ ID NO: 1, wherein the position 2′ of the 2′-substituted nucleotides is —R1, —OR1, —R2OR1, —OR2OR1 or —R3OR2OR1, wherein R1 represents a C1-4 alkyl group, and R2 and R3 independently represent a C1-3 alkylene group.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GENECARE RESEARCH INSTITUTE CO LTDKAMAKURA-SHI KANAGAWA 247-0063

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Furuichi, Yasuhiro Kamakura-shi, Kanagawa, JP 26 89
Futami, Kazunobu Fujisawa-shi, Kanagawa, JP 7 38
Kaneto, Satoshi Kamakura-shi, Kanagawa, JP 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation